Next Article in Journal
Formulation of Topical Drug Delivery Systems Containing a Fixed-Dose Isoniazid–Rifampicin Combination Using the Self-Emulsification Mechanism
Next Article in Special Issue
Synthesis and Characterization of Transferrin Receptor-Targeted Peptide Combination SN-38 and Rucaparib Conjugate for the Treatment of Glioblastoma
Previous Article in Journal
Novel Drug–Drug Cocrystalline Forms of Carbamazepine with Sulfacetamide: Preparation, Characterization, and In Vitro/In Vivo Performance Evaluation
Previous Article in Special Issue
Metformin-Based Combination Approaches for Triple-Negative Breast Cancer
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(6), 679; https://doi.org/10.3390/pharmaceutics17060679
Action Date Notes Link
article xml file uploaded 22 May 2025 10:22 CEST Original file -
article xml uploaded. 22 May 2025 10:22 CEST Update https://www.mdpi.com/1999-4923/17/6/679/xml
article pdf uploaded. 22 May 2025 10:22 CEST Version of Record https://www.mdpi.com/1999-4923/17/6/679/pdf
article supplementary file uploaded. 22 May 2025 10:22 CEST - https://www.mdpi.com/1999-4923/17/6/679#supplementary
article html file updated 22 May 2025 10:24 CEST Original file -
article html file updated 25 June 2025 05:32 CEST Update https://www.mdpi.com/1999-4923/17/6/679/html
Back to TopTop